Weight loss peptides (GLP-1 agonists) Examples : Semaglutide, Tirzepatide, Liraglutide Common side effects (mostly GI-related): Nausea : Frequency: 40-50% of users initially Severity: Mild to moderate Duration: Usually 1-3 weeks (improves with continued use) Management: Start low dose, increase gradually, eat smaller meals Constipation : Frequency: 20-30% of users Severity: Mild to moderate Management: Increase fiber, water, consider stool softener Diarrhea : Frequency: 15-20% of users Severity: Mild Duration: Usually temporary Management: Probiotics, reduce fatty foods Fatigue : Frequency: 20-30% initially Severity: Mild to moderate Duration: 2-4 weeks (improves as caloric deficit stabilizes) Management: Adequate protein, electrolytes, patience Reduced appetite (intended effect): Not a side effect - this is the mechanism Goal: 15-20% reduction in caloric intake Result: Weight loss Read our semaglutide vs tirzepatide comparison
[DOI] [PubMed] [Google Scholar] 8.Alzhanov DT, et al
Use a fan, ice pack or cold flannel to cool the affected area and apply moisturizing lotion
BPC-157 is not designated for medical, diagnostic, or therapeutic applications
Peptides are the Latest Response to an Ongoing Epidemic AS MORE PEOPLE stay indoors and stare at screens, the American Academy of Ophthalmology has flagged an ongoing myopia epidemic
